162 related articles for article (PubMed ID: 24742047)
1. KCNK3: new gene target for pulmonary hypertension?
Girerd B; Perros F; Antigny F; Humbert M; Montani D
Expert Rev Respir Med; 2014 Aug; 8(4):385-7. PubMed ID: 24742047
[TBL] [Abstract][Full Text] [Related]
2. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
[TBL] [Abstract][Full Text] [Related]
3. An homozygous mutation in KCNK3 is associated with an aggressive form of hereditary pulmonary arterial hypertension.
Navas Tejedor P; Tenorio Castaño J; Palomino Doza J; Arias Lajara P; Gordo Trujillo G; López Meseguer M; Román Broto A; Lapunzina Abadía P; Escribano Subía P
Clin Genet; 2017 Mar; 91(3):453-457. PubMed ID: 27649371
[TBL] [Abstract][Full Text] [Related]
4. Genetic counselling in a national referral centre for pulmonary hypertension.
Girerd B; Montani D; Jaïs X; Eyries M; Yaici A; Sztrymf B; Savale L; Parent F; Coulet F; Godinas L; Lau EM; Tamura Y; Sitbon O; Soubrier F; Simonneau G; Humbert M
Eur Respir J; 2016 Feb; 47(2):541-52. PubMed ID: 26699722
[TBL] [Abstract][Full Text] [Related]
5. A novel channelopathy in pulmonary arterial hypertension.
Ma L; Roman-Campos D; Austin ED; Eyries M; Sampson KS; Soubrier F; Germain M; Trégouët DA; Borczuk A; Rosenzweig EB; Girerd B; Montani D; Humbert M; Loyd JE; Kass RS; Chung WK
N Engl J Med; 2013 Jul; 369(4):351-361. PubMed ID: 23883380
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Heterozygous
Bohnen MS; Roman-Campos D; Terrenoire C; Jnani J; Sampson KJ; Chung WK; Kass RS
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28889099
[TBL] [Abstract][Full Text] [Related]
7. Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.
Cunningham KP; Holden RG; Escribano-Subias PM; Cogolludo A; Veale EL; Mathie A
J Physiol; 2019 Feb; 597(4):1087-1101. PubMed ID: 30365877
[TBL] [Abstract][Full Text] [Related]
8. A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension.
Higasa K; Ogawa A; Terao C; Shimizu M; Kosugi S; Yamada R; Date H; Matsubara H; Matsuda F
BMC Pulm Med; 2017 Apr; 17(1):57. PubMed ID: 28388887
[TBL] [Abstract][Full Text] [Related]
9. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
[TBL] [Abstract][Full Text] [Related]
10. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
11. Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension.
Navas P; Tenorio J; Quezada CA; Barrios E; Gordo G; Arias P; López Meseguer M; Santos-Lozano A; Palomino Doza J; Lapunzina P; Escribano Subías P
Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1011-1019. PubMed ID: 27453251
[TBL] [Abstract][Full Text] [Related]
12. The genetic basis of pulmonary arterial hypertension.
Ma L; Chung WK
Hum Genet; 2014 May; 133(5):471-9. PubMed ID: 24442418
[TBL] [Abstract][Full Text] [Related]
13. Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
Redel-Traub G; Sampson KJ; Kass RS; Bohnen MS
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291551
[TBL] [Abstract][Full Text] [Related]
14. Characterization of
Lambert M; Capuano V; Boet A; Tesson L; Bertero T; Nakhleh MK; Remy S; Anegon I; Pechoux C; Hautefort A; Rucker-Martin C; Manoury B; Domergue V; Mercier O; Girerd B; Montani D; Perros F; Humbert M; Antigny F
Circ Res; 2019 Sep; 125(7):678-695. PubMed ID: 31347976
[TBL] [Abstract][Full Text] [Related]
15. KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.
West JD; Austin ED; Rizzi EM; Yan L; Tanjore H; Crabtree AL; Moore CS; Muthian G; Carrier EJ; Jacobson DA; Hamid R; Kendall PL; Majka S; Rathinasabapathy A
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065088
[TBL] [Abstract][Full Text] [Related]
16. Heritable forms of pulmonary arterial hypertension.
Austin ED; Loyd JE
Semin Respir Crit Care Med; 2013 Oct; 34(5):568-80. PubMed ID: 24037626
[TBL] [Abstract][Full Text] [Related]
17. Mutations in BMPR2 are not present in patients with pulmonary hypertension associated with congenital diaphragmatic hernia.
Chiu JS; Ma L; Wynn J; Krishnan U; Rosenzweig EB; Aspelund G; Arkovitz M; Warner BW; Lim FY; Mychaliska GB; Azarow K; Cusick RA; Chung DH; Chung WK
J Pediatr Surg; 2017 Nov; 52(11):1747-1750. PubMed ID: 28162765
[TBL] [Abstract][Full Text] [Related]
18. Genetics of pulmonary hypertension.
Best DH; Austin ED; Chung WK; Elliott CG
Curr Opin Cardiol; 2014 Nov; 29(6):520-7. PubMed ID: 25159282
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells.
Le Ribeuz H; Dumont F; Ruellou G; Lambert M; Balliau T; Quatredeniers M; Girerd B; Cohen-Kaminsky S; Mercier O; Yen-Nicolaÿ S; Humbert M; Montani D; Capuano V; Antigny F
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036472
[TBL] [Abstract][Full Text] [Related]
20. The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.
Haarman MG; Kerstjens-Frederikse WS; Vissia-Kazemier TR; Breeman KTN; Timens W; Vos YJ; Roofthooft MTR; Hillege HL; Berger RMF
J Pediatr; 2020 Oct; 225():65-73.e5. PubMed ID: 32502478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
